Ian Shakil is CHIEF STRATEGY OFFICER of Augmedix, Inc.. Currently has a direct ownership of 0 shares of AUGX, which is worth approximately $0. The most recent transaction as insider was on Mar 28, 2024, when has been sold 31,994 shares (Common Stock) at a price of $4.06 per share, resulting in proceeds of $129,895. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Ian Shakil Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 28 2024
SELL
Open market or private sale
$129,895 $4.06 p/Share
31,994 Reduced 14.57%
187,666 Common Stock
Dec 03 2021
BUY
Grant, award, or other acquisition
$10,200 $3.4 p/Share
3,000 Added 1.35%
219,660 Common Stock
Oct 05 2020
BUY
Grant, award, or other acquisition
-
216,660 Added 50.0%
216,660 Common Stock
IS

Ian Shakil

CHIEF STRATEGY OFFICER
San Francisco, CA

Track Institutional and Insider Activities on AUGX

Follow Augmedix, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUGX shares.

Notify only if

Insider Trading

Get notified when an Augmedix, Inc. insider buys or sells AUGX shares.

Notify only if

News

Receive news related to Augmedix, Inc.

Track Activities on AUGX